GH and IGF1 levels decline with aging, concordant with loss of muscle and bone mass and an increase in fat deposition and BMI [21], and selected studies have reported an association between prostate cancer and blood IGF1 [22,23] or genetic variants in IGF1 [24] or IGFBP3 [25]. This evidence concerns the gene IGF1 and prostate carcinoma.